166 related articles for article (PubMed ID: 25771075)
1. Telomere shortening in mucosa surrounding the tumor: biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Rampazzo E; Perissinotto E; Piano MA; Giunco S; Baboci L; Spinato G; Spinato R; Tirelli G; Da Mosto MC; Del Mistro A; De Rossi A
Oral Oncol; 2015 May; 51(5):500-7. PubMed ID: 25771075
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Rampazzo E; Polesel J; Giunco S; Menegaldo A; Mantovani M; Stellin M; Bandolin L; Spinato G; Del Mistro A; Borsetto D; Fussey J; Tirelli G; Da Mosto MC; De Rossi A
Sci Rep; 2019 Nov; 9(1):17572. PubMed ID: 31772219
[TBL] [Abstract][Full Text] [Related]
3. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
Boscolo-Rizzo P; Da Mosto MC; Rampazzo E; Giunco S; Del Mistro A; Menegaldo A; Baboci L; Mantovani M; Tirelli G; De Rossi A
Cancer Metastasis Rev; 2016 Sep; 35(3):457-74. PubMed ID: 27501725
[TBL] [Abstract][Full Text] [Related]
4. TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.
Boscolo-Rizzo P; Giunco S; Rampazzo E; Brutti M; Spinato G; Menegaldo A; Stellin M; Mantovani M; Bandolin L; Rossi M; Del Mistro A; Tirelli G; Dei Tos AP; Guerriero A; Niero M; Da Mosto MC; Polesel J; De Rossi A
J Cancer Res Clin Oncol; 2020 Feb; 146(2):381-389. PubMed ID: 31960186
[TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
6. Increased PGE2 levels in nonmalignant mucosa adjacent to squamous cell carcinoma of the head and neck.
Schuon R; Brieger J; Franke RL; Jakob R; Mann WJ
ORL J Otorhinolaryngol Relat Spec; 2005; 67(2):96-100. PubMed ID: 15821352
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and telomerase subunits as diagnostic and prognostic biomarkers in Barrett carcinoma.
Gertler R; Doll D; Maak M; Feith M; Rosenberg R
Cancer; 2008 May; 112(10):2173-80. PubMed ID: 18348304
[TBL] [Abstract][Full Text] [Related]
8. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Mao L; El-Naggar AK; Fan YH; Lee JS; Lippman SM; Kayser S; Lotan R; Hong WK
Cancer Res; 1996 Dec; 56(24):5600-4. PubMed ID: 8971162
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.
Homann N; Nees M; Conradt C; Dietz A; Weidauer H; Maier H; Bosch FX
Clin Cancer Res; 2001 Feb; 7(2):290-6. PubMed ID: 11234882
[TBL] [Abstract][Full Text] [Related]
11. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot study.
Roesch-Ely M; Leipold A; Nees M; Holzinger D; Dietz A; Flechtenmacher C; Wolf T; Zapatka M; Bosch FX
J Pathol; 2010 Aug; 221(4):462-70. PubMed ID: 20593486
[TBL] [Abstract][Full Text] [Related]
13. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
14. The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma.
Carkic J; Nikolic N; Radojevic-Skodric S; Kuzmanovic-Pficer J; Brajovic G; Antunovic M; Milasin J; Popovic B
J Oral Sci; 2016; 58(4):449-458. PubMed ID: 28025427
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
[TBL] [Abstract][Full Text] [Related]
16. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma.
Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ
Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351
[TBL] [Abstract][Full Text] [Related]
17. Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
Fernández-Marcelo T; Sánchez-Pernaute A; Pascua I; De Juan C; Head J; Torres-García AJ; Iniesta P
PLoS One; 2016; 11(2):e0149626. PubMed ID: 26913901
[TBL] [Abstract][Full Text] [Related]
18. hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Barczak W; Suchorska WM; Sobecka A; Bednarowicz K; Machczynski P; Golusinski P; Rubis B; Masternak MM; Golusinski W
Mol Med Rep; 2017 Jul; 16(1):441-446. PubMed ID: 28535013
[TBL] [Abstract][Full Text] [Related]
19. FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck.
Pattje WJ; Melchers LJ; Slagter-Menkema L; Mastik MF; Schrijvers ML; Gibcus JH; Kluin PM; Hoegen-Chouvalova O; van der Laan BF; Roodenburg JL; van der Wal JE; Schuuring E; Langendijk JA
Histopathology; 2013 Aug; 63(2):263-70. PubMed ID: 23763459
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition.
Fernández-Marcelo T; Morán A; de Juan C; Pascua I; Head J; Gómez A; Hernando F; López-Asenjo JA; Hernández S; Sánchez-Pernaute A; Torres AJ; Benito M; Iniesta P
Oncology; 2012; 82(3):153-64. PubMed ID: 22433385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
